Home/ Supplements/ Vitamin A/ Enervimin Stress Focus

Enervimin Stress Focus

product on market Tablet or Pill Energique Nutrition Safety: 94/100
94/100

This product looks safe

  • Beta-Carotene: 4.5mg is 1.5× the Tolerable Upper Intake Level (3.0mg)
  • Niacin/Niacinamide: 120mg is 3.4× the Tolerable Upper Intake Level (35mg)
  • Folic Acid: 800mg is 800.0× the Tolerable Upper Intake Level (1.0mg)
  • Manganese: 15mg is 1.4× the Tolerable Upper Intake Level (11mg)
  • In a 500 mg. proprietary blend of: 500mg is 1.4× the Tolerable Upper Intake Level (350mg)
  • 69% of ingredients have research evidence
F Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This profile consists of essential vitamins and antioxidants that support immune function and cellular health. There is strong evidence for the roles of vitamins C, D3, and E in maintaining systemic wellness. However, the overall evidence coverage for this specific formulation is limited.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Beta-Carotene: 4.5mg is 1.5× the Tolerable Upper Intake Level (3.0mg)

Niacin/Niacinamide: 120mg is 3.4× the Tolerable Upper Intake Level (35mg)

Folic Acid: 800mg is 800.0× the Tolerable Upper Intake Level (1.0mg)

Manganese: 15mg is 1.4× the Tolerable Upper Intake Level (11mg)

In a 500 mg. proprietary blend of: 500mg is 1.4× the Tolerable Upper Intake Level (350mg)

Label

Product Label

Label for Enervimin Stress Focus
Open Full PDF View on NIH DSLD →
Details

Label Data

4 Tablet(s)
Serving Size
Other Combinations
Product Type
69%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

15000 IU
Exceeds UL by 1.5× (UL: 3.0 mg) 241 studies (A:5, B:97)
Vitamin A
5000 IU
Vitamin C
1000 mg
50 IU
Within RDA (0.1× RDA) 608 studies (A:16, B:251)
200 IU
8.9× RDA — above typical dose (UL: 1000 mg) 179 studies (A:3, B:90)
50 mg
41.7× RDA — above typical dose 76 studies (A:0, B:33)
25 mg
19.2× RDA — above typical dose 13 studies (A:0, B:1)
Exceeds UL by 3.4× (UL: 35 mg) 196 studies (A:5, B:63)
25 mg
19.2× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
800 mg
Exceeds UL by 800.0× (UL: 1.0 mg) 226 studies (A:10, B:105)
100 mcg
41.7× RDA — above typical dose 139 studies (A:1, B:44)
300 mcg
10.0× RDA — above typical dose 27 studies (A:0, B:11)
30.0× RDA — above typical dose 2 studies — no high-quality reviews
Calcium
300 mg
300 mg
Within RDA (0.7× RDA) 316 studies (A:8, B:159)
20 mg
1.8× RDA — within safe limits 263 studies (A:6, B:134)
200 mcg
3.6× RDA — above typical dose (UL: 0.4 mg) 173 studies (A:0, B:67)
2 mg
2.2× RDA — within safe limits 37 studies (A:0, B:11)
15 mg
Exceeds UL by 1.4× (UL: 11 mg) 9 studies — no high-quality reviews
200 mcg
5.7× RDA — above typical dose 199 studies (A:1, B:55)
50 mcg
1.1× RDA — within safe limits 3 studies — no high-quality reviews
Potassium
75 mg
20 mg
Market median: 125.0mg (294 products) 38 studies (A:1, B:7)
25 mg
Market median: 550.0mg (217 products) 29 studies (A:0, B:5)
Market median: 500.0mg (283 products) 174 studies (A:0, B:62)
50 mg
Market median: 500.0mg (9 products) 7 studies — no high-quality reviews
25 mcg
Market median: 0.5mg (6 products) 1 studies (A:0, B:1)
1 mg
Market median: 3.0mg (58 products) 3 studies — no high-quality reviews
Exceeds UL by 1.4× (UL: 350 mg) 316 studies (A:8, B:159)
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Additional Information

Energique's EnerViMin Stress Focus is formulated to boost the body's defenses against stress.

120 tablets bottle.

Metadata

Product Details

DSLD Entry Date2012-10-25
Product TypeOther Combinations
FormTablet or Pill
DSLD ID13107
Data Updated2026-04-11
Research

Research Evidence

337
Research Sources
54
Avg Quality
161
Meta Analysis
68
Systematic Review
51
Rct
48
Clinical Trial
2
Other
2
Regulatory Source
1
Narrative Review
1
Cochrane Review
1
Guideline
1
Openfda Safety
A Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Vitamin A supplementation for the prevention of morbidity and mortality in infants six months of age or less
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
A Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
A Vitamin A supplements for preventing mortality, illness, and blindness in children aged under 5: systematic review and meta-analysis
Meta Analysis BMJ (Clinical research ed.) 2011 PubMed DOI
A Fortification of staple foods with vitamin A for vitamin A deficiency
Systematic Review The Cochrane database of systematic reviews 2019 PubMed DOI
A Vitamin A supplementation for the prevention of morbidity and mortality in infants one to six months of age
Narrative Review The Cochrane database of systematic reviews 2016 PubMed DOI
A Vitamin A and fish oils for preventing the progression of retinitis pigmentosa
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Exercise training-induced changes in exerkine concentrations may be relevant to the metabolic control of type 2 diabetes mellitus patients: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Journal of sport and health science 2023 PubMed DOI
A Food fortification with multiple micronutrients: impact on health outcomes in general population
Meta Analysis The Cochrane database of systematic reviews 2019 PubMed DOI
A Oral vitamin A supplements to prevent acute upper respiratory tract infections in children up to seven years of age
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
View all evidence for Vitamin A →
Compare

Similar Products

View all Vitamin A products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.